Mucinex Instasoothe Lozenge
FDA Label NDC 72854-268

15 label sections · Submitted to the FDA by Reckitt Benckiser Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Reckitt Benckiser Llc for the product Mucinex Instasoothe (NDC 72854-268). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients (in each lozenge), purpose, uses, warnings, do not use, otc - when using, otc - stop use, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Sore throat warning: If sore throat is severe, persists for more than 2 days,
is accompanied or followed by fever, headache, rash, swelling, nausea,
or vomiting, consult a doctor promptly.

Dist. by: Reckitt Benckiser
Nutley, NJ 07110-6100

Do Not Use

  • in children under 6 years of age

* Please review the disclaimer below.